Dr. Li Describes the Future of Lung Cancer Therapy | OncLive

Dr. Li Describes the Future of Lung Cancer Therapy

September 19, 2011

Dr. Tianhong Li from University of California Davis Cancer Center Describes the Future of Lung Cancer Therapy

Tianhong (Tina) Li, MD, PhD, assistant professor, co-director of Phase I Program, UC Davis Cancer Center, believes the future of lung cancer will involve a shift towards personalized care.

There is quite a lot of heterogeneity in lung tumors making the detection of mutations, such as ALK for the use of crizotinib (Xalkori), more important. This type of genetic testing should become more heavily used to determine future treatments.


x